Checkpoint inhibitor-associated cutaneous small vessel vasculitis

Brianna Castillo; Julie Gibbs; Andrew S Brohl; Lucia Seminario-Vidal

doi:10.1016/j.jdcr.2018.05.020

Checkpoint inhibitor-associated cutaneous small vessel vasculitis

JAAD Case Rep. 2018 Aug 11;4(7):675-677. doi: 10.1016/j.jdcr.2018.05.020. eCollection 2018 Aug.

Authors

Brianna Castillo¹, Julie Gibbs², Andrew S Brohl³, Lucia Seminario-Vidal^{2

3}

Affiliations

¹ Aventura Hospital and Medical Center, Aventura, Florida.
² University of South Florida Morsani College of Medicine, Tampa, Florida.
³ Moffitt Cancer Center, Tampa, Florida.

No abstract available

Keywords: CTLA-4, cytotoxic T-lymphocyte–associated antigen 4; GPA, granulomatosis polyangiitis; PD-1, programmed cell death 1 receptor; PD-L1, PD-1 ligand; checkpoint inhibitor; drug reaction; ipilimumab; pembroluzimab; vasculitis.

Publication types

Case Reports